| Year |
Citation |
Score |
| 2020 |
Berman AN, Biery DW, Singh A, Wu WY, Divakaran S, DeFilippis EM, Hainer J, Blaha MJ, Cannon C, Polk DM, Plutzky J, Natarajan P, Nasir K, Carli MFD, Bhatt DL, et al. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. European Journal of Preventive Cardiology. 2047487320931296. PMID 32539451 DOI: 10.1177/2047487320931296 |
0.31 |
|
| 2020 |
Palermo NE, Goodberlet M, Cromwell G, Smith CM, Chang L, Bilodeau A, Plutzky J, Szumita PM, Hulme O, Cannon C, Mcdonnell ME. 2218-PUB: Initiation of SGLT2 Inhibitors in Hospitalized Patients with CVD Diabetes. 69. DOI: 10.2337/Db20-2218-Pub |
0.306 |
|
| 2019 |
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, Bowman L, Braunwald E, Byington R, Cannon C, Clearfield M, Colhoun H, Collins R, Dahlöf B, Davies K, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials The Lancet. 393: 407-415. PMID 30712900 DOI: 10.1016/S0140-6736(18)31942-1 |
0.344 |
|
| 2019 |
Divakaran S, Singh A, Biery D, Yang J, DeFilippis EM, Collins B, Ramsis M, Qamar A, Hainer J, Klein J, Cannon C, Polk DM, Plutzky J, Nasir K, Carli MD, et al. Diabetes Is Associated With Worse Long-Term Outcomes In Young Adults After Myocardial Infarction: The Partners Young-Mi Registry Journal of the American College of Cardiology. 73: 2. DOI: 10.1016/S0735-1097(19)33764-7 |
0.304 |
|
| 2019 |
Peterson B, Bhatt DL, Kosiborod M, Ballantyne C, Lemos Jd, Rosenson R, Philip K, Mues K, Alam S, Liu Y, Cannon C. Intensity Of Lipid Lowering Therapy Among Patients With Polyvascular Disease: Insights From The Gould Registry Journal of the American College of Cardiology. 73: 241. DOI: 10.1016/S0735-1097(19)30849-6 |
0.311 |
|
| 2018 |
Bonaca MP, Gutierrez JA, Cannon C, Giugliano R, Blazing M, Park JG, White J, Tershakovec A, Braunwald E. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. The Lancet. Diabetes & Endocrinology. PMID 30396865 DOI: 10.1016/S2213-8587(18)30290-0 |
0.352 |
|
| 2018 |
Berg JT, Veer Ad, Oldgren J, Steg P, Zateyshchikov DA, Janský P, Seung K, Hohnloser S, Lip G, Nordaby M, Kleine E, Bhatt D, Cannon C. Is It Safe To Switch Oac In Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention? Results From A Re-Dual Pci Subanalysis Journal of the American College of Cardiology. 71. DOI: 10.1016/S0735-1097(18)31747-9 |
0.373 |
|
| 2018 |
Steg P, Bhatt D, Ellis S, Hohnloser S, Kleine E, Nordaby M, Simetzberger M, Kimura T, Lip G, Oldgren J, Berg JT, Cannon C, Bichat H. Bleeding Events And Their Consequences On Cardiovascular Events, Readmission And Net Clinical Benefit Journal of the American College of Cardiology. 71. DOI: 10.1016/S0735-1097(18)31695-4 |
0.384 |
|
| 2017 |
Larkin A, LaCouture M, Ernst F, Bates E, Cannon C, Bhatt D. Effect Of An Online Continuing Medical Education And Clinician Coaching Quality Improvement Initiative On Antiplatelet Medication Adherence And Hospital Readmissions In Patients With Acute Coronary Syndrome Journal of the American College of Cardiology. 69: 2489. DOI: 10.1016/S0735-1097(17)35878-3 |
0.318 |
|
| 2017 |
White WB, Cushman W, Kupfer S, Bakris G, Bergenstal R, Heller S, Mehta C, Nissen S, Zannad F, Liu Y, Cannon C. Average Clinician Measured Blood Pressure Predict Cardiovascular Outcomes In Patients With Type 2 Diabetes Following Acute Coronary Syndromes In The Examine Trial Journal of the American College of Cardiology. 69: 1676. DOI: 10.1016/S0735-1097(17)35065-9 |
0.365 |
|
| 2017 |
Sharma A, Cannon C, Liu Y, White W, Zannad F. Early Versus Late Cardiovascular Events In Patients With Type 2 Diabetes Mellitus And Acute Coronary Syndrome: Insights From The Examine Trial Journal of the American College of Cardiology. 69: 186. DOI: 10.1016/S0735-1097(17)33575-1 |
0.382 |
|
| 2016 |
Gutierrez A, Bonaca M, Cannon C, Giugliano R, Park J, White JA, Tershakovec A, Braunwald E. POLYVASCULAR DISEASE, DIABETES MELLITUS AND LONG-TERM VASCULAR RISK: INSIGHTS FROM THE IMPROVE-IT TIMI 40 TRIAL Journal of the American College of Cardiology. 67: 2264. DOI: 10.1016/S0735-1097(16)32265-3 |
0.303 |
|
| 2016 |
May EAB, Morrow D, Cannon C, Giugliano R, Blazing M, He P, Murphy S, Jennifer W, Kesaniemi A, Pedersen T, Brady AJ, Mitchel YB, Tershakovec A, Braunwald E. ATHEROTHROMBOTIC RISK STRATIFICATION AND EZETIMIBE USE IN IMPROVE-IT Journal of the American College of Cardiology. 67: 2129. DOI: 10.1016/S0735-1097(16)32130-1 |
0.345 |
|
| 2016 |
Vaduganathan M, Bhatt D, Cryer BL, Liu Y, Hsieh W, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook T, Lapuerta P, Goldsmith MA, Laine L, Cannon C. PROTON-PUMP INHIBITORS REDUCE RISK OF GASTROINTESTINAL EVENTS REGARDLESS OF ASPIRIN DOSE IN PATIENTS REQUIRING DUAL ANTIPLATELET THERAPY: INSIGHTS FROM THE COGENT TRIAL Journal of the American College of Cardiology. 67: 2100. DOI: 10.1016/S0735-1097(16)32101-5 |
0.325 |
|
| 2016 |
Silverman MG, Cannon C, Blazing M, Mach F, Zhou J, Tershakovec A, Giugliano R. Long Term Significance Of Heart Failure Complicating Acute Myocardial Infarction In 11,185 Patients From The Improved Reduction Of Outcomes: Vytorin Efficacy International Trial (Improve-It) Journal of the American College of Cardiology. 67: 484. DOI: 10.1016/S0735-1097(16)30485-5 |
0.34 |
|
| 2016 |
Cavallari I, Cannon C, Braunwald E, Goodrich E, Im K, Lukas MA, O'Donoghue M. METABOLIC SYNDROME AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME: INSIGHTS FROM SOLID-TIMI 52 TRIAL Journal of the American College of Cardiology. 67: 448. DOI: 10.1016/S0735-1097(16)30449-1 |
0.372 |
|
| 2016 |
Fanola C, Morrow D, Cannon C, Jarolim P, Lukas MA, Goodrich E, Braunwald E, O'Donoghue M. INTERLEUKIN-6 AND THE RISK OF ADVERSE OUTCOMES IN PATIENTS AFTER AN ACUTE CORONARY SYNDROME: OBSERVATIONS FROM THE SOLID-TIMI 52 TRIAL Journal of the American College of Cardiology. 67: 442. DOI: 10.1016/S0735-1097(16)30443-0 |
0.323 |
|
| 2015 |
Magnani G, O’Donoghue M, Braunwald E, Steen D, Jarolim P, Lukas MA, White H, Lewis B, Winter Rd, Zhou J, Im K, Cannon C, Morrow D. Galectin-3 For Heart Failure Risk Stratification In Patients After Acute Coronary Syndromes (Acs): Insights From The Solid-Timi 52 Trial Journal of the American College of Cardiology. 65. DOI: 10.1016/S0735-1097(15)60773-2 |
0.39 |
|
| 2015 |
Andell P, James S, Cannon C, Cyr D, Himmelmann A, Husted S, Keltai M, Koul S, Santoso A, Steg P, Storey R, Wallentin L, Erlinge D. Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes And Chronic Obstructive Pulmonary Disease: An Analysis From The Platelet Inhibition And Patient Outcomes (Plato) Trial Journal of the American College of Cardiology. 65. DOI: 10.1016/S0735-1097(15)60114-0 |
0.399 |
|
| 2015 |
Steen D, Cannon C, Daga S, Lukas MA, Ophuis AO, Gratsiansky N, Crugnale S, Shannon JB, O’Donoghue M. Performance Reports And The Utilization Of Guideline-Based Therapies In A Large Clinical Trial Population Enrolled After An Acute Coronary Syndrome: Insights From The Solid-Timi 52 Trial Journal of the American College of Cardiology. 65. DOI: 10.1016/S0735-1097(15)60070-5 |
0.359 |
|
| 2015 |
Giugliano RP, Cannon C, Blazing M, White J, Murphy S, Tershakovec A, Musliner T, Califf R, Braunwald E. BASELINE LDL-C AND CLINICAL OUTCOMES WITH ADDITION OF EZETIMIBE TO STATIN IN 18,144 PATIENTS POST ACS Journal of the American College of Cardiology. 65: A4. DOI: 10.1016/S0735-1097(15)60004-3 |
0.332 |
|
| 2015 |
May EAB, White JA, Blazing M, Giugliano R, Musliner T, Tershakovec A, McCagg A, Bhatt D, Cannon C, Califf R, Braunwald E. RISK STRATIFICATION FOR CARDIOVASCULAR EVENTS IN THE IMPROVE-IT TRIAL Journal of the American College of Cardiology. 65: A3. DOI: 10.1016/S0735-1097(15)60003-1 |
0.356 |
|
| 2014 |
Blankstein R, Cannon C, Udelson J. Update on pharmacological cardiac stress testing: efficacy, risk stratification and patient selection. The American Journal of Medicine. 127: e16-7. PMID 25447629 DOI: 10.1016/J.Amjmed.2014.10.008 |
0.321 |
|
| 2014 |
Kotsia A, Brilakis ES, Held C, Cannon C, Steg GP, Meier B, Cools F, Claeys MJ, Cornel JH, Aylward P, Lewis BS, Weaver D, Brandrup-Wognsen G, Stevens SR, Himmelmann A, et al. Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. American Heart Journal. 168: 68-75.e2. PMID 24952862 DOI: 10.1016/J.Ahj.2014.04.001 |
0.406 |
|
| 2014 |
Bui A, Cannon C, Steg P, Storey R, Husted S, Ren F, James S, Michelson E, Himmelmann A, Wallentin L, Scirica B. Risk Of Cardiovascular Death And Non-Sustained Ventricular Tachycardia Detected 30-Days After Acute Coronary Syndrome In The Plato (Platelet Inhibition And Patient Outcomes) Trial Journal of the American College of Cardiology. 63. DOI: 10.1016/S0735-1097(14)60298-9 |
0.4 |
|
| 2014 |
Zannad F, Cannon C, Cushman W, Bakris G, Nissen S, Heller S, Bergenstal R, Menon V, Perez A, Fleck P, Oh R, Mehta C, Kupfer S, Wilson CA, White W. Alogliptin In Patients With Type 2 Diabetes After Acute Coronary Syndromes: Heart Failure Outcomes And Cardiovascular Safety In Heart Failure Patients Journal of the American College of Cardiology. 63. DOI: 10.1016/S0735-1097(14)60117-0 |
0.355 |
|
| 2014 |
Lindholm D, James S, Bertilsson M, Cannon C, Giannitsis E, Harrington R, Himmelmann A, Kontny F, Siegbahn A, Steg P, Velders M, Weaver WD, Wallentin L. Biomarkers For Prediction Of Outcomes In Revascularized Patients With Non-St-Elevation Acute Coronary Syndrome: A Plato Substudy Journal of the American College of Cardiology. 63. DOI: 10.1016/S0735-1097(14)60045-0 |
0.369 |
|
| 2013 |
Cannon C, Ezekowitz MD, Granger C. Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation The American Journal of Cardiology. 112. PMID 23910054 DOI: 10.1016/J.Amjcard.2013.06.003 |
0.301 |
|
| 2013 |
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 382: 769-79. PMID 23726390 DOI: 10.1016/S0140-6736(13)60900-9 |
0.338 |
|
| 2013 |
James S, Storey RF, Cannon C, Janzon M, Nicolau JC, Parasuraman B, Mellstrom K, Wallentin L, Henriksson M. Health economic evaluation of ticagrelor compared to generic clopidogrel in patients with acute coronary syndromes intended for non-invasive management based on the PLATO trial European Heart Journal. 34: 896-896. DOI: 10.1093/Eurheartj/Eht310.P4901 |
0.36 |
|
| 2013 |
Bansilal S, Wiviott S, Becker R, Harrington R, Himmelmann A, Neely B, Husted S, Storey R, Steg P, Katus H, James S, Wallentin L, Cannon C. The Efficacy And Safety Of Ticagrelor As Compared To Clopidogrel, With And Without A Glycoprotein Iib/Iiia Inhibitor In Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A Plato (Study Of Platelet Inhibition And Patient Outcomes) Analysis Journal of the American College of Cardiology. 61. DOI: 10.1016/S0735-1097(13)61858-6 |
0.375 |
|
| 2013 |
Lindholm D, Varenhorst C, Cannon C, Harrington R, Himmelmann A, Maya J, Husted S, Katus H, Steg P, Storey R, Wallentin L, James SK. Ticagrelor versus clopidogrel in patients with non-st-elevation acute coronary syndrome : results from the PLATO trial Journal of the American College of Cardiology. 61. DOI: 10.1016/S0735-1097(13)60002-9 |
0.396 |
|
| 2012 |
Bui AH, Cannon C, Steg P, Storey R, Husted S, Ren F, James S, Michelson E, Horrow J, Wallentin L, Scirica B. Relationship Between Nonsustained Ventricular Tachycardia And Vascular Death In Patients With Acute Coronary Syndrome In The Plato (Platelet Inhibition And Patient Outcomes) Trial Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)60630-5 |
0.392 |
|
| 2012 |
Husted S, James S, Becker R, Horrow J, Katus H, Storey R, Cannon C, Heras M, Lopes R, Morais J, Mahaffey K, Bach R, Wojdyla D, Wallentin L. Ticagrelor Versus Clopidogrel In Women With Acute Coronary Syndromes – A Substudy From The Prospective Randomized Platelet Inhibition And Patient Outcomes (Plato) Trial Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)60508-7 |
0.375 |
|
| 2012 |
Storey RF, James S, Åsenblad N, Siegbahn A, Emanuelsson H, Katus H, Cannon C, Husted S, Steg P, Wallentin L. Consistent Benefit Of Ticagrelor Compared To Clopidogrel In Acute Coronary Syndrome Patients Regardless Of Baseline Inflammatory Markers Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)60506-3 |
0.374 |
|
| 2012 |
Kohli P, Morrow D, Murphy S, Cannon C, Ridker P, Braunwald E, Sabatine M. PROGNOSTIC VALUE OF SERIAL C-REACTIVE PROTEIN LEVELS AFTER AN ACUTE CORONARY SYNDROME: AN ANALYSIS FROM PROVE-IT TIMI 22 Journal of the American College of Cardiology. 59: E399. DOI: 10.1016/S0735-1097(12)60400-8 |
0.321 |
|
| 2011 |
Acharjee S, Cannon C. The Role of Ticagrelor in Acute Coronary Syndromes International Journal of Clinical Reviews. DOI: 10.5275/Ijcr.2011.06.01 |
0.346 |
|
| 2010 |
Marchini J, Morrow D, Resnic F, Manica A, Kirshenbaum J, Cannon C, Croce K. An Algorithm for use of Prasugrel (Effient) in Patients Undergoing Cardiac Catheterization and Percutaneous Coronary Intervention Critical Pathways in Cardiology: a Journal of Evidence-Based Medicine. 9: 192-198. PMID 21119336 DOI: 10.1097/Hpc.0B013E3181Fe9817 |
0.385 |
|
| 2004 |
Pillai M, DiBattiste P, Murphy S, Morrow D, Cannon C, Lakkis NM. 884-5 Impact of Troponin Status and Coronary Artery Disease by Angiography on Outcome in Acute Coronary Syndrome: A TACTICS TIMI-18 Substudy Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)91297-1 |
0.348 |
|
| 1997 |
Bovill EG, Tracy RP, Knatterud GL, Stone PH, Nasmith J, Gore JM, Thompson BW, Tofler GH, Kleiman NS, Cannon C, Braunwald E. Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial). The American Journal of Cardiology. 79: 391-6. PMID 9052337 DOI: 10.1016/S0002-9149(96)00773-4 |
0.342 |
|
| Show low-probability matches. |